ISOPP CAPhO 2025 Symposium: Acting Today to Protect our Patients from Late Treatment-related Toxicities

With the increasingly impressive survival rates in pediatric oncology, it has become even more imperative to ensure that survivors of childhood cancers enjoy healthy lives as adults. Mitigation or prevention of known late effects of treatment such as cardiotoxicity and ototoxicity will be discussed. Evidence to support the use of prophylaxis under specific circumstances and the attendant controversies will be summarized. Interventions currently under study to prevent late treatment effects will be presented.

Learning Objectives

• Recall the clinical circumstances where cardiotoxicity and ototoxicity can be effectively and safely minimized in pediatric patients with cancer
• Evaluate the risks and benefits of interventions aimed at preventing cardiotoxicity and ototoxicity
• Identify interventions that may prove to be effective in preventing cardiotoxicity and ototoxicity